Study reveals that specific body shape phenotypes, such as general obesity and central obesity, significantly increase the risk of colorectal cancer, suggesting distinct molecular pathways for different adiposity subtypes.
Merck’s Keytruda sales eclipse $18B on the year, while numbers for Lagevrio surprise
Merck’s blockbuster cancer drug Keytruda made $18.4 billion in the first nine months of the year — nearly the same amount as the reported revenue
October 27, 2023